市場調査レポート
商品コード
1420114

セファロスポリン医薬品の世界市場:世代別、投与経路別、用途別、地域別、国別の分析、市場考察、予測

Global Cephalosporin Drug Market : Analysis by Generation, Route of Administration, Application, By Region, By Country: Market Insights and Forecast

出版日: | 発行: Azoth Analytics | ページ情報: 英文 260 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
セファロスポリン医薬品の世界市場:世代別、投与経路別、用途別、地域別、国別の分析、市場考察、予測
出版日: 2024年02月01日
発行: Azoth Analytics
ページ情報: 英文 260 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のセファロスポリン医薬品の市場規模は、2022年の132億7,000万米ドルから2029年末までに219億米ドルに達すると予測されます。世界のセファロスポリン医薬品市場の有利な成長要因は、細菌感染症の流行、抗生物質耐性パターン、規制承認、新しい製剤の導入によって推進されています。2024年~2029年の予測期間に世界のセファロスポリン医薬品はCAGRで7.5%の拡大が見込まれます。製薬企業は、耐性菌に対抗するため、先進の世代のセファロスポリン製剤の開発に注力しています。新世代の開発、併用療法、徐放性製剤、適応症の拡大などが、いずれもセファロスポリン医薬品の進化に寄与しています。

呼吸器感染症、尿路感染症、皮膚・軟部組織感染症、腹腔内感染症などの細菌感染症の世界中での高い罹患率とその増加は、重要な促進要因です。セファロスポリンは、これらの感染症の治療に一般的に処方される抗生物質であり、セファロスポリン医薬品の需要が促進されています。

世界の医薬品サプライチェーンは、パンデミック中、ロックダウン、輸送制限、工場閉鎖による混乱に直面しました。これらの混乱は、セファロスポリン医薬品を含む医薬品の生産、流通、入手に影響を与えました。しかし、影響を緩和し、必要不可欠な医薬品の継続的な供給を確保する活動がなされました。また、パンデミックは進行中の臨床試験を中断させ、セファロスポリン医薬品の開発に関連する臨床試験を含む新たな臨床試験の開始を遅らせました。この中断は、新しいセファロスポリンの導入や、その利用の拡大に関するスケジュールに影響を与えた可能性があります。

進行中の研究開発では、吸入可能な製剤や新しい呼吸器デバイスなど、先進のドラッグデリバリーシステムの開発が行われています。これらの技術は、セファロスポリン医薬品の気道への標的送達を強化し、有効性を向上させ、副作用を最小限に抑えることを目的としています。

徐放性製剤は、セファロスポリン製剤を長時間にわたって徐々に放出するように設計されており、投与回数を減らすことができます。これにより、患者の服薬アドヒアランスと利便性が向上します。放出制御機構などのドラッグデリバリー技術の進歩により、治療効果の持続性が確保され、急速な薬剤放出に伴う副作用のリスクが軽減される可能性があります。

医薬品製造における連続製造プロセスは、効率性、費用対効果、品質管理の面で利点があります。これらのプロセスをセファロスポリンの製造に応用することで、より合理的でスケーラブルな製造パイプラインが実現します。また、スマートパッケージングでは、RFID(Radio-Frequency Identification)やQRコードのような技術を取り入れることで、医薬品の保管状況をモニターし、有効期限を追跡し、製品全体の完全性を高めることができます。これにより、ライフサイクルを通してセファロスポリン医薬品の品質と安定性が保証されます。

当レポートでは、世界のセファロスポリン医薬品市場について調査し、市場規模と予測、地域とセグメントの分析、主要動向と機会などの情報を提供しています。

目次

第1章 市場の背景

  • 範囲と製品の見通し
  • エグゼクティブサマリー
  • 調査手法

第2章 戦略的推奨事項

第3章 世界のセファロスポリン医薬品市場:実績と予測(2019年~2029年)

  • 世界のセファロスポリン医薬品市場に対するマクロ経済要因の影響の分析
  • パイプラインのシナリオ
  • 世界の抗菌薬耐性に関連した死亡者数
  • 疫学:世界の感染症の有病率
  • 疫学:世界の感染症の罹患率
  • 世界のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
  • セファロスポリン医薬品市場に対するCOVID-19の影響度
  • 世界のセファロスポリン医薬品市場セグメンテーション:世代別
    • 世界のセファロスポリン医薬品市場:世代別、概要
    • 世界のセファロスポリン医薬品の市場規模:第1世代(金額)(2019年~2029年)
    • 世界のセファロスポリン医薬品の市場規模:第2世代(金額)(2019年~2029年)
    • 世界のセファロスポリン医薬品の市場規模:第3世代(金額)(2019年~2029年)
    • 世界のセファロスポリン医薬品の市場規模:第4世代(金額)(2019年~2029年)
    • 世界のセファロスポリン医薬品の市場規模:第5世代(金額)(2019年~2029年)
  • 世界のセファロスポリン医薬品市場セグメンテーション:投与経路別
    • 世界のセファロスポリン医薬品市場:投与経路別、概要
    • 世界のセファロスポリン医薬品の市場規模:経口(金額)(2019年~2029年)
    • 世界のセファロスポリン医薬品の市場規模:非経口(金額)(2019年~2029年)
  • 世界のセファロスポリン医薬品市場セグメンテーション:用途別
    • 世界のセファロスポリン医薬品市場:用途別、概要
    • 世界のセファロスポリン医薬品の市場規模:気道感染症(金額)(2019年~2029年)
    • 世界のセファロスポリン医薬品の市場規模:皮膚感染症(金額)(2019年~2029年)
    • 世界のセファロスポリン医薬品の市場規模:尿路感染症(金額)(2019年~2029年)
    • 世界のセファロスポリン医薬品の市場規模:その他(金額)(2019年~2029年)

第4章 世界のセファロスポリン医薬品市場、地域分析

  • 研究の地域範囲
  • 地域のスナップショット

第5章 南北アメリカのセファロスポリン医薬品市場:実績と予測(2019年~2029年)

  • 南北アメリカのセファロスポリン医薬品市場:スナップショット
  • 南北アメリカのセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
  • 南北アメリカのセファロスポリン医薬品市場:主な要因
  • 南北アメリカのセファロスポリン医薬品市場:セグメント分析
  • 南北アメリカのセファロスポリン医薬品市場セグメンテーション:世代別
  • 南北アメリカのセファロスポリン医薬品市場セグメンテーション:投与経路別
  • 南北アメリカのセファロスポリン医薬品市場セグメンテーション:用途別
  • 南北アメリカのセファロスポリン医薬品市場セグメンテーション:国別
    • 南北アメリカのセファロスポリン医薬品市場:国別、概要
    • 米国のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • カナダのセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • その他の南北アメリカのセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)

第6章 欧州のセファロスポリン医薬品市場:実績と予測(2019年~2029年)

  • 欧州のセファロスポリン医薬品市場:スナップショット
  • 欧州のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
  • 欧州のセファロスポリン医薬品市場:主な要因
  • 欧州のセファロスポリン医薬品市場:セグメント分析
  • 欧州のセファロスポリン医薬品市場セグメンテーション:世代別
  • 欧州のセファロスポリン医薬品市場セグメンテーション:投与経路別
  • 欧州のセファロスポリン医薬品市場セグメンテーション:用途別
  • 欧州のセファロスポリン医薬品市場セグメンテーション:国別
    • 欧州のセファロスポリン医薬品市場:国別、概要
    • 英国のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • ドイツのセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • フランスのセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • イタリアのセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • その他の欧州のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)

第7章 アジア太平洋のセファロスポリン医薬品市場:実績と予測(2019年~2029年)

  • アジア太平洋のセファロスポリン医薬品市場:スナップショット
  • アジア太平洋のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
  • アジア太平洋のセファロスポリン医薬品市場:主な要因
  • アジア太平洋のセファロスポリン医薬品市場:セグメント分析
  • アジア太平洋のセファロスポリン医薬品市場セグメンテーション:世代別
  • アジア太平洋のセファロスポリン医薬品市場セグメンテーション:投与経路別
  • アジア太平洋のセファロスポリン医薬品市場セグメンテーション:用途別
  • アジア太平洋のセファロスポリン医薬品市場セグメンテーション:国別
    • アジア太平洋のセファロスポリン医薬品市場:国別、概要
    • 中国のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • 日本のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • 韓国のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • インドのセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
    • その他のアジア太平洋のセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)

第8章 中東・アフリカのセファロスポリン医薬品市場:実績と予測(2019年~2029年)

  • 中東・アフリカのセファロスポリン医薬品市場:スナップショット
  • 中東・アフリカのセファロスポリン医薬品市場:市場規模とCAGR(2019年~2029年)
  • 中東・アフリカのセファロスポリン医薬品市場:主な要因
  • 中東・アフリカのセファロスポリン医薬品市場:セグメント分析
  • 中東・アフリカのセファロスポリン医薬品市場セグメンテーション:世代別
  • 中東・アフリカのセファロスポリン医薬品市場セグメンテーション:投与経路別
  • 中東・アフリカのセファロスポリン医薬品市場セグメンテーション:用途別

第9章 市場力学

  • 世界のセファロスポリン医薬品市場に対する市場力学の影響の評価
  • 促進要因
  • 抑制要因
  • 動向

第10章 産業エコシステム分析

  • ポーターのファイブフォース分析

第11章 競合ポジショニング

  • 企業の製品ポジショニング
  • 主要企業の市場シェア
  • 企業プロファイル
    • Lupin Limited
    • Baxter International
    • F. Hoffmann-La Roche AG
    • Eli Lilly and Company
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Novartis
    • Sanofi
    • Pfizer
    • Teva Pharmaceutical
図表

List of Figures

List of Figures

  • Figure 1: Global deaths associated with bacterial antimicrobial resistance by infectious syndrome, 2019
  • Figure 2: Global Cephalosporin Drug Market Size, By Value, 2019-2022 (USD Million)
  • Figure 3: Global Cephalosporin Drug Market Size, By Value, 2023-2029 (USD Million)
  • Figure 4: Global Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 5: Global Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 6: Global Cephalosporin Drug Market Absolute Opportunity, By First Generation, 2019H-2029F (USD Million)
  • Figure 7: Global Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 8: Global Cephalosporin Drug Market Absolute Opportunity, By Second Generation, 2019H-2029F (USD Million)
  • Figure 9: Global Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 10: Global Cephalosporin Drug Market Absolute Opportunity, By Third Generation, 2019H-2029F (USD Million)
  • Figure 11: Global Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 12: Global Cephalosporin Drug Market Absolute Opportunity, By Fourth Generation, 2019H-2029F (USD Million)
  • Figure 13: Global Cephalosporin Drug Market Size, By Fifth Generation , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 14: Global Cephalosporin Drug Market Absolute Opportunity, By Fifth Generation, 2019H-2029F (USD Million)
  • Figure 15: Global Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 16: Global Cephalosporin Drug Market Absolute Opportunity, By Oral, 2019H-2029F (USD Million)
  • Figure 17: Global Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 18: Global Cephalosporin Drug Market Absolute Opportunity, By Parenteral, 2019H-2029F (USD Million)
  • Figure 19: Global Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 20: Global Cephalosporin Drug Market Absolute Opportunity, By Respiratory Tract Infection, 2019H-2029F (USD Million)
  • Figure 21: Global Cephalosporin Drug Market Size, By Skin Infection , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 22: Global Cephalosporin Drug Market Absolute Opportunity, By Skin Infection , 2019H-2029F (USD Million)
  • Figure 23: Global Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 24: Global Cephalosporin Drug Market Absolute Opportunity, By Urinary Tract Infection, 2019H-2029F (USD Million)
  • Figure 25: Global Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 26: Global Cephalosporin Drug Market Absolute Opportunity, By Others, 2019H-2029F (USD Million)
  • Figure 27: Americas Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 28: Americas Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 29: Americas Cephalosporin Drug Market, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 30: Americas Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 31: Americas Cephalosporin Drug Market, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 32: Americas Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 33: Americas Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 34: Americas Cephalosporin Drug Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 35: Americas Cephalosporin Drug Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 36: Americas Cephalosporin Drug Market, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 37: Americas Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 38: Americas Cephalosporin Drug Market, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 39: Americas Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 40: United States Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 41: United States Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 42: United States Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 43: United States Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 44: United States Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 45: Canada Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 46: Canada Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 47: Canada Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 48: Canada Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 49: Canada Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 50: Rest of Americas Cephalosporin Drug Market , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 51: Rest of Americas Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 52: Rest of Americas Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 53: Rest of Americas Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 54: Rest of Americas Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 55: Europe Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 56: Europe Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 57: Europe Cephalosporin Drug Market, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 58: Europe Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 59: Europe Cephalosporin Drug Market, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 60: Europe Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 61: Europe Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 62: Europe Cephalosporin Drug Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 63: Europe Cephalosporin Drug Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 64: Europe Cephalosporin Drug Market, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 65: Europe Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 66: Europe Cephalosporin Drug Market, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 67: Europe Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 68: United Kingdom Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 69: United Kingdom Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 70: United Kingdom Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 71: United Kingdom Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 72: United Kingdom Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 73: Germany Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 74: Germany Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 75: Germany Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 76: Germany Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 77: Germany Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 78: France Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 79: France Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 80: France Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 81: France Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 82: France Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 83: Italy Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 84: Italy Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 85: Italy Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 86: Italy Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 87: Italy Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 88: Rest of Europe Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 89: Rest of Europe Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 90: Rest of Europe Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 91: Rest of Europe Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 92: Rest of Europe Cephalosporin Drug MarketShare, By Application, By Value, 2022 (%)
  • Figure 93: Asia-Pacific Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 94: Asia-Pacific Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 95: Asia-Pacific Cephalosporin Drug Market, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 96: Asia-Pacific Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 97: Asia-Pacific Cephalosporin Drug Market, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 98: Asia-Pacific Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 99: Asia-Pacific Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 100: Asia-Pacific Cephalosporin Drug Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 101: Asia-Pacific Cephalosporin Drug Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 102: Asia-Pacific Cephalosporin Drug Market, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 103: Asia-Pacific Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 104: Asia-Pacific Cephalosporin Drug Market, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 105: Asia-Pacific Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 106: China Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 107: China Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 108: China Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 109: China Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 110: China Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 111: Japan Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 112: Japan Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 113: Japan Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 114: Japan Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 115: Japan Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 116: South Korea Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 117: South Korea Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 118: South Korea Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 119: South Korea Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 120: South Korea Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 121: India Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 122: India Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 123: India Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 124: India Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 125: India Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 126: Rest of Asia-Pacific Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 127: Rest of Asia-Pacific Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 128: Rest of Asia-Pacific Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 129: Rest of Asia-Pacific Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 130: Rest of Asia-Pacific Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 131: Middle East and Africa Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 132: Middle East and Africa Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 133: Middle East and Africa Cephalosporin Drug Market , By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 134: Middle East and Africa Cephalosporin Drug Market , By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 135: Middle East and Africa Cephalosporin Drug Market , By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 136: Middle East and Africa Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 137: Middle East and Africa Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 138: Middle East and Africa Cephalosporin Drug Market , By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 139: Middle East and Africa Cephalosporin Drug Market , By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 140: Middle East and Africa Cephalosporin Drug Market , By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 141: Middle East and Africa Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 142: Middle East and Africa Cephalosporin Drug Market , By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 143: Middle East and Africa Cephalosporin Drug Market , By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 144: Global Impact of Drivers and Restraints
  • Figure 145: Market Share of Prominent Companies of Cephalosporin Drug, 2022 (%)
  • Figure 146: Lupin Revenues, 2020-2022 (USD Million)
  • Figure 147: Lupin Revenues, By Geographic Segments, 2022 (%)
  • Figure 148: Lupin Revenue , By Business Segments, 2022 (%)
  • Figure 149: Baxter International Revenues, 2020-2022 (USD Million)
  • Figure 150: Baxter International Revenues, By Geographic Segments, 2022 (%)
  • Figure 151: Baxter International Revenue , By Business Segments, 2022 (%)
  • Figure 152: Roche Revenues, 2020-2022 (USD Million)
  • Figure 153: Roche Revenue , By Business Segment, 2022 (%)
  • Figure 154: Eli Lilly and Company Revenues, 2020-2022 (USD Million)
  • Figure 155: Eli Lilly and Company Revenues, By Geographic Segments, 2022 (%)
  • Figure 156: Eli Lilly and Company Revenue , By Therapeutic Area, 2022 (%)
  • Figure 157: Abbott Laboratories Revenues, 2020-2022 (USD Million)
  • Figure 158: Abbott Laboratories Revenues, By Geographic Segments, 2022 (%)
  • Figure 159: Abbott Laboratories Revenue , By Business Segments, 2022 (%)
  • Figure 160: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
  • Figure 161: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
  • Figure 162: Merck & Co., Inc. Revenue , By Business Segments, 2022 (%)
  • Figure 163: Novartis Revenues, 2020-2022 (USD Million)
  • Figure 164: Novartis Revenue , By Business Segments, 2022 (%)
  • Figure 165: Novartis Revenue , By Geographical Segments, 2022 (%)
  • Figure 166: Sanofi Revenues, 2020-2022 (USD Million)
  • Figure 167: Sanofi Revenues, By Geographic Segments, 2022 (%)
  • Figure 168: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 169: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 170: Pfizer Revenues, By Business Segments, 2022 (%)
  • Figure 171: Pfizer Inc. Revenue , By Geographical Segments, 2022 (%)
  • Figure 172: Teva Pharmaceuticals Revenues, 2020-2022 (USD Million)
  • Figure 173: Teva Pharmaceuticals Revenue , By Geographical Segments, 2022 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Cephalosporin Drug in Pipeline

Table A3: United States Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A4: United States Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A5: United States Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A6: United States Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A7: United States Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A8: United States Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A9: Canada Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A10: Canada Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A11: Canada Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A12: Canada Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A13: Canada Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A14: Canada Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A15: Rest of Americas Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A16: Rest of Americas Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A17: Rest of Americas Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A18: Rest of Americas Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A19: Rest of Americas Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A20: Rest of Americas Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A21: United Kingdom Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A22: United Kingdom Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A23: United Kingdom Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A24: United Kingdom Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A25: United Kingdom Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A26: United Kingdom Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A27: Germany Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A28: Germany Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A29: Germany Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A30: Germany Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A31: Germany Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A32: Germany Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A33: France Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A34: France Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A35: France Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A36: France Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A37: France Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A38: France Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A39: Italy Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A40: Italy Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A41: Italy Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A42: Italy Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A43: Italy Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A44: Italy Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A45: Rest of Europe Cephalosporin Drug Market , By Generation, By Value, 2019-2022 (USD Million)

Table A46: Rest of Europe Cephalosporin Drug Market , By Generation, By Value, 2023-2029 (USD Million)

Table A47: Rest of Europe Cephalosporin Drug Market , By Route of Administration, By Value, 2019-2022 (USD Million)

Table A48: Rest of Europe Cephalosporin Drug Market , By Route of Administration, By Value, 2023-2029 (USD Million)

Table A49: Rest of Europe Cephalosporin Drug Market , By Application, By Value, 2019-2022 (USD Million)

Table A50: Rest of Europe Cephalosporin Drug Market , By Application, By Value, 2023-2029 (USD Million)

Table A51: China Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A52: China Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A53: China Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A54: China Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A55: China Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A56: China Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A57: Japan Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A58: Japan Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A59: Japan Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A60: Japan Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A61: Japan Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A62: Japan Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A63: South Korea Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A64: South Korea Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A65: South Korea Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A66: South Korea Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A67: South Korea Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A68: South Korea Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A69: India Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A70: India Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A71: India Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A72: India Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A73: India Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A74: India Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A75: Rest of Asia-Pacific Cephalosporin Drug Market, By Generation Industry, By Value, 2019-2022 (USD Million)

Table A76: Rest of Asia-Pacific Cephalosporin Drug Market, By Generation Industry, By Value, 2023-2029 (USD Million)

Table A77: Rest of Asia-Pacific Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A78: Rest of Asia-Pacific Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A79: Rest of Asia-Pacific Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A80: Rest of Asia-Pacific Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A81: Lupin Key Financials, 2020-2022

Table A82: Baxter International Key Financials, 2020-2022

Table A83: Roche Key Financials, 2020-2022

Table A84: Eli Lilly and Company Key Financials, 2020-2022

Table A85: Abbott Laboratories Key Financials, 2020-2022

Table A86: Merck & Co., Inc. Key Financials, 2020-2022

Table A87: Novartis Key Company Financials, 2020-2022

Table A88: Sanofi Key Financials, 2020-2022

Table A89: Pfizer Key Financials, 2020-2022

Table A90: Teva Pharmaceuticals Key Company Financials, 2020-2022

目次

Executive Summary

Azoth Analytics has released a research report titled "Global Cephalosporin Drug Market (2024 Edition)" which provides a complete analysis of the Global Cephalosporin Drug industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), By Route of Administration (Oral, Parenteral), By Application (Respiratory Tract Infection, Skin Infection, Urinary Tract Infection, Others), By Region (Americas , Europe, Asia-pacific, Middle-East & Africa), for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Italy, China, Japan, South Korea, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Cephalosporin Drug Market is expected to generate USD 21.9 Billion by the end of 2029, up from USD 13.27 Billion in 2022. A favourable growth element for the global Cephalosporin Drug market is propelled by the prevalence of bacterial infections, antibiotic resistance patterns, regulatory approvals, and the introduction of new formulations. During the forecast period, 2024-2029, Global Cephalosporin Drug is expected to expand at a CAGR of 7.5%. Pharmaceutical companies have focused on developing advanced generations of Cephalosporin drugs to combat bacterial resistance. The development of new generations, combination therapies, extended-release formulations, and expanded indications all contribute to the evolving landscape of Cephalosporin drugs.

The high and growing incidence of bacterial infections worldwide, such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections, is a significant driving factor. Cephalosporins are commonly prescribed antibiotics for treating these infections, which fuels the demand for Cephalosporin drugs.

The global pharmaceutical supply chains faced disruptions due to lockdowns, transportation restrictions, and factory closures during the pandemic. These disruptions affected the production, distribution, and availability of pharmaceutical products, including Cephalosporin drugs. However, efforts were made to mitigate the impact and ensure a continued supply of essential medications. Also, the pandemic disrupted ongoing clinical trials and delayed the initiation of new trials, including those related to the development of Cephalosporin drugs. This interruption may have impacted the timeline for introducing new Cephalosporins or exploring their expanded uses.

According to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), Globally, the incidence of Upper Respiratory Infection reached 17*2 billion. Ongoing research involves the development of advanced drug delivery systems, such as inhalable formulations or novel respiratory devices. These technologies aim to enhance the targeted delivery of cephalosporin drugs to the respiratory tract, improving efficacy and minimizing side effects.

Extended-release formulations are designed to release the cephalosporin drug gradually over an extended period, allowing for less frequent dosing. This can lead to improved patient adherence and convenience. Advances in drug delivery technologies, such as controlled-release mechanisms, ensure a sustained therapeutic effect and potentially reduce the risk of side effects associated with rapid drug release.

Continuous manufacturing processes in pharmaceutical production offer advantages in terms of efficiency, cost-effectiveness, and quality control. Applying these processes to cephalosporin production contribute to a more streamlined and scalable manufacturing pipeline. Also, Smart packaging involves incorporating technologies like RFID (Radio-Frequency Identification) or QR codes to monitor drug storage conditions, track expiration dates, and enhance overall product integrity. This ensures the quality and stability of cephalosporin drugs throughout their lifecycle.

Scope of the Report

  • The report analyses the Cephalosporin Drug Market by Value (USD Million).
  • The report presents the analysis of the Cephalosporin Drug Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
  • The report analyses the Cephalosporin Drug Market by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation).
  • The report analyses the Cephalosporin Drug Market by Route of Administration (Oral, Parenteral).
  • The report analyses the Cephalosporin Drug Market by Application (Respiratory Tract Infection, Skin Infection, Urinary Tract Infection, Others).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Lupin Limited, Baxter International, F. Hoffmann-La Roche AG, Eli Lilly and Company, Abbott Laboratories, Merck & Co., Inc., Novartis, Sanofi, Pfizer, Teva Pharmaceutical.

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Strategic Recommendations

3. Global Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 3.1 Impact Analysis of Macro Economic Factors on Global Cephalosporin Drug Market
  • 3.2 Pipeline Scenario
  • 3.3 Global deaths associated with bacterial antimicrobial resistance
  • 3.4 Epidemiology: Global Infectious Disease Prevalence
  • 3.5 Epidemiology: Global Infectious Disease Incidence
  • 3.6 Global Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 3.7 Degree of Impact of Covid-19 on Cephalosporin Drug Market
  • 3.8 Global Cephalosporin Drug Market Segmentation : By Generation
    • 3.8.1 Global Cephalosporin Drug Market, By Generation Overview
    • 3.8.2 Global Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.3 Global Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.4 Global Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.5 Global Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.6 Global Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 3.9 Global Cephalosporin Drug Market Segmentation : By Route of Administration
    • 3.9.1 Global Cephalosporin Drug Market, By Route of Administration Overview
    • 3.9.2 Global Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.9.3 Global Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 3.10 Global Cephalosporin Drug Market Segmentation : By Application
    • 3.10.1 Global Cephalosporin Drug Market, By Application Overview
    • 3.10.2 Global Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.3 Global Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.4 Global Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.5 Global Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)

4. Global Cephalosporin Drug Market, Regional Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 5.1 Americas Cephalosporin Drug Market: Snapshot
  • 5.2 Americas Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 5.3 Americas Cephalosporin Drug Market: Key Factors
  • 5.4 Americas Cephalosporin Drug Market: Segment Analysis
  • 5.5 Americas Cephalosporin Drug Market Segmentation : By Generation
    • 5.5.1 Americas Cephalosporin Drug Market, By Generation Overview
    • 5.5.2 Americas Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.3 Americas Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.4 Americas Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.5 Americas Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.6 Americas Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.6 Americas Cephalosporin Drug Market Segmentation : By Route of Administration
    • 5.6.1 Americas Cephalosporin Drug Market, By Route of Administration Overview
    • 5.6.2 Americas Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.6.3 Americas Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.7 Americas Cephalosporin Drug Market Segmentation : By Application
    • 5.7.1 Americas Cephalosporin Drug Market, By Application Overview
    • 5.7.2 Americas Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.3 Americas Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.4 Americas Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.5 Americas Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.8 Americas Cephalosporin Drug Market Segmentation : By Country
    • 5.8.1 Americas Cephalosporin Drug Market, By Country Overview
    • 5.8.2 United States Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.8.2.1 United States Cephalosporin Drug Market, By Generation
      • 5.8.2.2 United States Cephalosporin Drug Market, By Route of Administration
      • 5.8.2.3 United States Cephalosporin Drug Market, By Application
    • 5.8.3 Canada Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.8.3.1 Canada Cephalosporin Drug Market, By Generation
      • 5.8.3.2 Canada Cephalosporin Drug Market, By Route of Administration
      • 5.8.3.3 Canada Cephalosporin Drug Market, By Application
    • 5.10.4 Rest of Americas Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.10.4.1 Rest of Americas Cephalosporin Drug Market, By Generation
      • 5.10.4.2 Rest of Americas Cephalosporin Drug Market, By Route of Administration
      • 5.10.4.3 Rest of Americas Cephalosporin Drug Market, By Application

6. Europe Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 6.1 Europe Cephalosporin Drug Market: Snapshot
  • 6.2 Europe Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 6.3 Europe Cephalosporin Drug Market: Key Factors
  • 6.4 Europe Cephalosporin Drug Market: Segment Analysis
  • 6.5 Europe Cephalosporin Drug Market Segmentation : By Generation
    • 6.5.1 Europe Cephalosporin Drug Market, By Generation Overview
    • 6.5.2 Europe Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.3 Europe Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.4 Europe Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.5 Europe Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.6 Europe Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.6 Europe Cephalosporin Drug Market Segmentation : By Route of Administration
    • 6.6.1 Europe Cephalosporin Drug Market, By Route of Administration Overview
    • 6.6.2 Europe Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.6.3 Europe Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.7 Europe Cephalosporin Drug Market Segmentation : By Application
    • 6.7.1 Europe Cephalosporin Drug Market, By Application Overview
    • 6.5.2 Europe Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.3 Europe Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.4 Europe Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.7.5 Europe Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.8 Europe Cephalosporin Drug Market Segmentation : By Country
    • 6.8.1 Europe Cephalosporin Drug Market, By Country Overview
    • 6.8.2 United Kingdom Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.2.1 United Kingdom Cephalosporin Drug Market, By Generation
      • 6.8.2.2 United Kingdom Cephalosporin Drug Market, By Route of Administration
      • 6.8.2.3 United Kingdom Cephalosporin Drug Market, By Application
    • 6.8.3 Germany Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.3.1 Germany Cephalosporin Drug Market, By Generation
      • 6.8.3.2 Germany Cephalosporin Drug Market, By Route of Administration
      • 6.8.3.3 Germany Cephalosporin Drug Market, By Application
    • 6.8.4 France Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.4.1 France Cephalosporin Drug Market, By Generation
      • 6.8.4.2 France Cephalosporin Drug Market, By Route of Administration
      • 6.8.4.3 France Cephalosporin Drug Market, By Application
    • 6.8.5 Italy Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.5.1 Italy Cephalosporin Drug Market, By Generation
      • 6.8.5.2 Italy Cephalosporin Drug Market, By Route of Administration
      • 6.8.5.3 Italy Cephalosporin Drug Market, By Application
    • 6.8.6 Rest of Europe Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.6.1 Rest of Europe Cephalosporin Drug Market, By Generation
      • 6.8.6.2 Rest of Europe Cephalosporin Drug Market, By Route of Administration
      • 6.8.6.3 Rest of Europe Cephalosporin Drug Market, By Application

7. Asia Pacific Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 7.1 Asia Pacific Cephalosporin Drug Market: Snapshot
  • 7.2 Asia Pacific Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 7.3 Asia Pacific Cephalosporin Drug Market: Key Factors
  • 7.4 Asia Pacific Cephalosporin Drug Market: Segment Analysis
  • 7.5 Asia Pacific Cephalosporin Drug Market Segmentation : By Generation
    • 7.5.1 Asia Pacific Cephalosporin Drug Market, By Generation Overview
    • 7.5.2 Asia Pacific Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.3 Asia Pacific Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.4 Asia Pacific Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.5 Asia Pacific Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.6 Asia Pacific Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.6 Asia Pacific Cephalosporin Drug Market Segmentation : By Route of Administration
    • 7.6.1 Asia Pacific Cephalosporin Drug Market, By Route of Administration Overview
    • 7.6.2 Asia Pacific Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.6.3 Asia Pacific Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.7 Asia Pacific Cephalosporin Drug Market Segmentation : By Application
    • 7.7.1 Asia Pacific Cephalosporin Drug Market, By ApplicationOverview
    • 7.7.2 Asia Pacific Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.3 Asia Pacific Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.4 Asia Pacific Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.5 Asia Pacific Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.8 Asia Pacific Cephalosporin Drug Market Segmentation : By Country
    • 7.8.1 Asia Pacific Cephalosporin Drug Market, By Country Overview
    • 7.8.2 China Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.2.1 China Cephalosporin Drug Market, By Generation
      • 7.8.2.2 China Cephalosporin Drug Market, By Route of Administration
      • 7.8.2.3 China Cephalosporin Drug Market, By Application
    • 7.8.3 Japan Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.3.1 Japan Cephalosporin Drug Market, By Generation
      • 7.8.3.2 Japan Cephalosporin Drug Market, By Route of Administration
      • 7.8.3.3 Japan Cephalosporin Drug Market, By Application
    • 7.8.4 South Korea Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.4.1 South Korea Cephalosporin Drug Market, By Generation
      • 7.8.4.2 South Korea Cephalosporin Drug Market, By Route of Administration
      • 7.8.4.3 South Korea Cephalosporin Drug Market, By Application
    • 7.8.5 India Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.5.1 India Cephalosporin Drug Market, By Generation
      • 7.8.5.2 India Cephalosporin Drug Market, By Route of Administration
      • 7.8.5.3 India Cephalosporin Drug Market, By Application
    • 7.8.6 Rest of Asia Pacific Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.6.1 Rest of Asia Pacific Cephalosporin Drug Market, By Generation
      • 7.8.6.2 Rest of Asia Pacific Cephalosporin Drug Market, By Route of Administration
      • 7.8.6.3 Rest of Asia Pacific Cephalosporin Drug Market, By Application

8. Middle East and Africa Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 8.1 Middle East and Africa Cephalosporin Drug Market: Snapshot
  • 8.2 Middle East and Africa Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 8.3 Middle East and Africa Cephalosporin Drug Market: Key Factors
  • 8.4 Middle East and Africa Cephalosporin Drug Market: Segment Analysis
  • 8.5 Middle East and Africa Cephalosporin Drug Market Segmentation : By Generation
    • 8.5.1 Middle East and Africa Cephalosporin Drug Market, By Generation Overview
    • 8.5.2 Middle East and Africa Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.3 Middle East and Africa Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.4 Middle East and Africa Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.5 Middle East and Africa Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.6 Middle East and Africa Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 8.6 Middle East and Africa Cephalosporin Drug Market Segmentation : By Route of Administration
    • 8.6.1 Middle East and Africa Cephalosporin Drug Market, By Route of Administration Overview
    • 8.6.2 Middle East and Africa Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.6.3 Middle East and Africa Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 8.7 Middle East and Africa Cephalosporin Drug Market Segmentation : By Application
    • 8.7.1 Middle East and Africa Cephalosporin Drug Market, By Application Overview
    • 8.7.2 Middle East and Africa Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.3 Middle East and Africa Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.4 Middle East and Africa Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.5 Middle East and Africa Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)

9. Market Dynamics

  • 9.1 Impact Assessment of Market Dynamics on the Global Cephalosporin Drug Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Porter's Five Forces Analysis

11. Competitive Positioning

  • 11.1 Companies' Product Positioning
  • 11.2 Market Share of Leading Companies
  • 11.3 Company Profiling
    • 11.3.1 Lupin Limited
    • 11.3.2 Baxter International
    • 11.4.3 F. Hoffmann-La Roche AG
    • 11.3.4 Eli Lilly and Company
    • 11.3.5 Abbott Laboratories
    • 11.3.6 Merck & Co., Inc.
    • 11.3.7 Novartis
    • 11.3.8 Sanofi
    • 11.3.9 Pfizer
    • 11.3.10 Teva Pharmaceutical